Detlev Biniszkiewicz - Jan 3, 2022 Form 4 Insider Report for iTeos Therapeutics, Inc. (ITOS)

Role
Director
Signature
/s/ Adi Osovsky, as Attorney-in-Fact
Stock symbol
ITOS
Transactions as of
Jan 3, 2022
Transactions value $
-$115,150
Form type
4
Date filed
1/4/2022, 08:41 PM
Previous filing
Jun 21, 2021
Next filing
Jun 10, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ITOS Common Stock Options Exercise $66.5K +3.5K $19.00 3.5K Jan 3, 2022 Direct F1
transaction ITOS Common Stock Sale -$182K -3.5K -100% $51.90 0 Jan 3, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ITOS Stock Option (Right to Buy) Options Exercise $0 -3.5K -21.07% $0.00 13.1K Jan 3, 2022 Common Stock 3.5K $19.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 11, 2021.